文献速递妇科

良性卵巢肿瘤女性的交界性卵巢肿瘤风险:一项队列研究

Risk of borderline ovarian tumors among women with benign ovarian tumors: A cohort study.
PubMed 文献 · Gynecol Oncol · 2017-11-23

这项丹麦全国性队列研究纳入1978-2012年诊断为良性卵巢肿瘤的139,466名女性,计算标准化发病比(SIR)。良性卵巢肿瘤患者后续交界性卵巢肿瘤风险升高(SIR 1.62,95%CI 1.43-1.82),浆液性和黏液性亚型风险均升高。风险主要在40岁前诊断良性卵巢肿瘤的女性中升高,且持续至诊断后9年。

要点

  • 良性卵巢肿瘤患者后续交界性卵巢肿瘤风险升高(SIR 1.62,95%CI 1.43-1.82)。
  • 浆液性(SIR 1.69,95%CI 1.39-2.03)和黏液性(SIR 1.75,95%CI 1.45-2.10)交界性肿瘤风险均升高。
  • 风险主要见于40岁前诊断良性卵巢肿瘤者,并持续至诊断后9年。

核心结论

  • 良性卵巢肿瘤女性具有长期升高的交界性卵巢肿瘤风险。
  • 由于本研究所有关联仅校正了诊断时年龄和日历时期,需要更多能够校正其他潜在混杂变量的研究来进一步理解这些关联。

研究设计与样本

  • 丹麦全国性队列研究,纳入1978-2012年诊断为良性卵巢肿瘤的全部丹麦女性(n=139,466)。
  • 队列与丹麦病理数据库链接,计算标准化发病比(SIR)及95%置信区间(CI)。

主要发现

  • 良性卵巢肿瘤女性后续交界性卵巢肿瘤风险升高(SIR 1.62,95%CI 1.43-1.82)。
  • 浆液性交界性卵巢肿瘤风险升高(SIR 1.69,95%CI 1.39-2.03)。
  • 黏液性交界性卵巢肿瘤风险升高(SIR 1.75,95%CI 1.45-2.10)。
  • 交界性卵巢肿瘤风险主要在40岁前诊断良性卵巢肿瘤的女性中升高。
  • 良性卵巢肿瘤诊断后风险升高持续至9年。

局限性

  • 本研究所有关联仅校正了诊断时年龄和日历时期,需要更多能够校正其他潜在混杂变量的研究来进一步理解这些关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: A growing number of studies suggest that some ovarian cancers can arise from benign and borderline ovarian tumors. However, studies on the association between benign and borderline ovarian tumors are lacking. We studied the overall- and histotype-specific risk of borderline ovarian tumors among women with a benign ovarian tumor. METHODS: This nationwide cohort study included all Danish women diagnosed with a benign ovarian tumor (n=139,466) during 1978-2012. The cohort was linked to the Danish Pathology Data Bank and standardized incidence ratios (SIR) with 95% confidence intervals (CI) were calculated. RESULTS: Women with benign ovarian tumors had increased risks for subsequent borderline ovarian tumors (SIR 1.62, 95% CI 1.43-1.82), and this applied to both serous (SIR 1.69, 95% CI 1.39-2.03) and mucinous (SIR 1.75, 95% CI 1.45-2.10) histotypes of borderline ovarian tumors. The risk for borderline ovarian tumors was primarily increased for women diagnosed with a benign ovarian tumor before 40years of age. The risk remained increased up to 9years after a benign ovarian tumor diagnosis. Finally, the associations did not change markedly when analyzed for the different histotypes of benign (solid and cystic tumors) and borderline (serous and mucinous tumors) ovarian tumors. CONCLUSIONS: Women with benign ovarian tumors have a long-term increased risk for borderline ovarian tumors. However, as all associations in this study were only adjusted for age and calendar period of diagnosis, more studies that are able to adjust for additional potential confounding variables are required to further understand these associations.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Guleria S, Jensen A, Kjær SK, et al. Risk of borderline ovarian tumors among women with benign ovarian tumors: A cohort study. Gynecol Oncol. 2017. PMID: 29174556. doi:10.1016/j.ygyno.2017.11.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。